Based on the effect of IL-33 or IL-33-induced FCGR3+CD103+ cDC1s on tumor therapy in mice, we propose several approaches to translate the antitumor effect of IL-33 observed in mice to humans (Fig. 5). The gene discussed is ITGAE; the disease is neoplasm.